Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00661_DB01396> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00661_DB01396 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB01396 label "DDI between Verapamil and Digitoxin - Verapamil may increase the serum concentration of Digitoxin by decreasing its metabolism and clearance. Monitor for changes in the therapeutic/adverse effects of Digitoxin if Verpamail is initiated, discontinued or dose changed. [drugbank_resource:DB00661_DB01396]" assertion.
- drugbank_resource:DB00661_DB01396 identifier "drugbank_resource:DB00661_DB01396" assertion.
- drugbank_resource:DB00661_DB01396 title "DDI between Verapamil and Digitoxin - Verapamil may increase the serum concentration of Digitoxin by decreasing its metabolism and clearance. Monitor for changes in the therapeutic/adverse effects of Digitoxin if Verpamail is initiated, discontinued or dose changed." assertion.